Dr. Ahmed Elgendy, an Egyptian physicist and professor at the University of Texas, has won the prestigious 2026 Marie Curie Award in nanotechnology for his groundbreaking research on cancer treatment. Elgendy, who graduated from Alexandria University's Faculty of Science, was chosen from over 900 scientists worldwide for his innovative approach to treating cancer using nanotechnology. His research focuses on using magnetic nanoparticles to target and destroy cancer cells.
Elgendy's research journey began in 2002, and his initial idea involved injecting cancer cells with magnetic nanoparticles and then using an external magnetic field to generate heat that would destroy the tumor. However, experiments on mice showed that the tumors disappeared even without reaching the required temperature for thermal destruction, leading his team to discover a new mechanism of action. This breakthrough has the potential to revolutionize cancer treatment.
According to Elgendy, this approach specifically targets "solid tumors," such as breast, prostate, lung, brain, and liver cancers. However, he noted that this technology is not suitable for blood cancers, such as leukemia. Elgendy's research has been conducted in collaboration with over 50 universities, and the next phase will involve expanding animal testing to ensure safety and monitor potential side effects.
Elgendy's achievement is a testament to Egypt's reputation for producing talented scientists. He encourages young Egyptians to pursue their goals, stating that success is within reach if they stay focused and work hard. Elgendy's win is a significant milestone for Egyptian scientists, who have made significant contributions to various fields.
The Marie Curie Award is a prestigious recognition of outstanding contributions to scientific research. Elgendy's win is a notable achievement for the Egyptian scientific community, and his research has the potential to make a significant impact on cancer treatment worldwide. His work has been recognized globally, and he is an inspiration to young scientists everywhere.
Elgendy's achievement also sends a message to European countries that have been critical of Egypt. He emphasizes that Egyptian scientists are among the best in the world and that their contributions should be recognized and valued. Elgendy's win is a reminder that Egypt's reputation as a hub for scientific excellence cannot be ignored.
The significance of Elgendy's achievement extends beyond the scientific community. It highlights the importance of investing in education and research and the potential for Egyptian scientists to make a positive impact globally. As Egypt continues to produce talented scientists like Elgendy, it is likely that the country's reputation as a hub for scientific excellence will continue to grow.
Key points
- Dr. Ahmed Elgendy wins 2026 Marie Curie Award for innovative cancer treatment research using nanotechnology.
- Elgendy's research targets solid tumors, such as breast and lung cancers, using magnetic nanoparticles.
- Elgendy's achievement is a testament to Egypt's reputation for producing talented scientists.
